 | • レポートコード：QY2112C03922 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,102,500 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料はレミマゾラムの世界市場の現状について調査・分析し、2027年までの市場を予測しました。レミマゾラムの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（2.5mg、20mg）、用途別市場規模（外科的麻酔、ICU鎮静、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・レミマゾラムの世界市場概要 ・メーカー別の競争状況、市場シェア ・レミマゾラムの種類別市場規模：2.5mg、20mg ・レミマゾラムの用途別市場規模：外科的麻酔、ICU鎮静、その他 ・北米のレミマゾラム市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのレミマゾラム市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのレミマゾラム市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のレミマゾラム市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのレミマゾラム市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Paion、Yichang Renfu Pharmaceutical、Jiangsu Hengrui Medicine、Cosmo Pharmaceuticals、Mundipharma、Pharmascience、Hana Pharm ・レミマゾラムのバリューチェーン・販売チャネル分析 ・レミマゾラムの世界市場動向 |
Remimazolam, sold under the brand name Byfavo, is a medication for the induction and maintenance of procedural sedation in adults for invasive diagnostic or surgical procedures lasting 30 minutes or less. is a benzodiazepine drug, developed by PAION AG in collaboration with several regional licensees as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in the induction of anesthesia and conscious sedation for minor invasive procedures. Remimazolam was found to have both a more rapid onset and a shorter duration than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.
Market Analysis and Insights: Global Remimazolam Market
The global Remimazolam market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
Global Remimazolam Scope and Segment
Remimazolam market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Remimazolam market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
2.5mg
20mg
Segment by Application
Surgical Anesthesia
ICU Sedation
Other
By Company
Paion
Yichang Renfu Pharmaceutical
Jiangsu Hengrui Medicine
Cosmo Pharmaceuticals
Mundipharma
Pharmascience
Hana Pharm
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Remimazolam Product Introduction
1.2 Market by Type
1.2.1 Global Remimazolam Market Size Growth Rate by Type
1.2.2 2.5mg
1.2.3 20mg
1.3 Market by Application
1.3.1 Global Remimazolam Market Size Growth Rate by Application
1.3.2 Surgical Anesthesia
1.3.3 ICU Sedation
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Remimazolam Sales Estimates and Forecasts 2016-2027
2.2 Global Remimazolam Revenue Estimates and Forecasts 2016-2027
2.3 Global Remimazolam Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Remimazolam Regions by Sales
2.4.1 Global Top Remimazolam Regions by Sales (2016-2021)
2.4.2 Global Top Remimazolam Regions by Sales (2022-2027)
2.5 Global Top Remimazolam Regions by Revenue
2.5.1 Global Top Remimazolam Regions by Revenue (2016-2021)
2.5.2 Global Top Remimazolam Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Remimazolam Sales by Manufacturers
3.1.1 Global Top Remimazolam Manufacturers by Sales (2016-2021)
3.1.2 Global Top Remimazolam Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Remimazolam Sales in 2020
3.2 Global Remimazolam Revenue by Manufacturers
3.2.1 Global Top Remimazolam Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Remimazolam Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Remimazolam Revenue in 2020
3.3 Global Remimazolam Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Remimazolam Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Remimazolam Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Remimazolam Sales by Type
4.1.1 Global Remimazolam Historical Sales by Type (2016-2021)
4.1.2 Global Remimazolam Forecasted Sales by Type (2022-2027)
4.1.3 Global Remimazolam Sales Market Share by Type (2016-2027)
4.2 Global Remimazolam Revenue by Type
4.2.1 Global Remimazolam Historical Revenue by Type (2016-2021)
4.2.2 Global Remimazolam Forecasted Revenue by Type (2022-2027)
4.2.3 Global Remimazolam Revenue Market Share by Type (2016-2027)
4.3 Global Remimazolam Price by Type
4.3.1 Global Remimazolam Price by Type (2016-2021)
4.3.2 Global Remimazolam Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Remimazolam Sales by Application
5.1.1 Global Remimazolam Historical Sales by Application (2016-2021)
5.1.2 Global Remimazolam Forecasted Sales by Application (2022-2027)
5.1.3 Global Remimazolam Sales Market Share by Application (2016-2027)
5.2 Global Remimazolam Revenue by Application
5.2.1 Global Remimazolam Historical Revenue by Application (2016-2021)
5.2.2 Global Remimazolam Forecasted Revenue by Application (2022-2027)
5.2.3 Global Remimazolam Revenue Market Share by Application (2016-2027)
5.3 Global Remimazolam Price by Application
5.3.1 Global Remimazolam Price by Application (2016-2021)
5.3.2 Global Remimazolam Price Forecast by Application (2022-2027)
6 North America
6.1 North America Remimazolam Market Size by Type
6.1.1 North America Remimazolam Sales by Type (2016-2027)
6.1.2 North America Remimazolam Revenue by Type (2016-2027)
6.2 North America Remimazolam Market Size by Application
6.2.1 North America Remimazolam Sales by Application (2016-2027)
6.2.2 North America Remimazolam Revenue by Application (2016-2027)
6.3 North America Remimazolam Market Size by Country
6.3.1 North America Remimazolam Sales by Country (2016-2027)
6.3.2 North America Remimazolam Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Remimazolam Market Size by Type
7.1.1 Europe Remimazolam Sales by Type (2016-2027)
7.1.2 Europe Remimazolam Revenue by Type (2016-2027)
7.2 Europe Remimazolam Market Size by Application
7.2.1 Europe Remimazolam Sales by Application (2016-2027)
7.2.2 Europe Remimazolam Revenue by Application (2016-2027)
7.3 Europe Remimazolam Market Size by Country
7.3.1 Europe Remimazolam Sales by Country (2016-2027)
7.3.2 Europe Remimazolam Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Remimazolam Market Size by Type
8.1.1 Asia Pacific Remimazolam Sales by Type (2016-2027)
8.1.2 Asia Pacific Remimazolam Revenue by Type (2016-2027)
8.2 Asia Pacific Remimazolam Market Size by Application
8.2.1 Asia Pacific Remimazolam Sales by Application (2016-2027)
8.2.2 Asia Pacific Remimazolam Revenue by Application (2016-2027)
8.3 Asia Pacific Remimazolam Market Size by Region
8.3.1 Asia Pacific Remimazolam Sales by Region (2016-2027)
8.3.2 Asia Pacific Remimazolam Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Remimazolam Market Size by Type
9.1.1 Latin America Remimazolam Sales by Type (2016-2027)
9.1.2 Latin America Remimazolam Revenue by Type (2016-2027)
9.2 Latin America Remimazolam Market Size by Application
9.2.1 Latin America Remimazolam Sales by Application (2016-2027)
9.2.2 Latin America Remimazolam Revenue by Application (2016-2027)
9.3 Latin America Remimazolam Market Size by Country
9.3.1 Latin America Remimazolam Sales by Country (2016-2027)
9.3.2 Latin America Remimazolam Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Remimazolam Market Size by Type
10.1.1 Middle East and Africa Remimazolam Sales by Type (2016-2027)
10.1.2 Middle East and Africa Remimazolam Revenue by Type (2016-2027)
10.2 Middle East and Africa Remimazolam Market Size by Application
10.2.1 Middle East and Africa Remimazolam Sales by Application (2016-2027)
10.2.2 Middle East and Africa Remimazolam Revenue by Application (2016-2027)
10.3 Middle East and Africa Remimazolam Market Size by Country
10.3.1 Middle East and Africa Remimazolam Sales by Country (2016-2027)
10.3.2 Middle East and Africa Remimazolam Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Paion
11.1.1 Paion Corporation Information
11.1.2 Paion Overview
11.1.3 Paion Remimazolam Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Paion Remimazolam Product Description
11.1.5 Paion Recent Developments
11.2 Yichang Renfu Pharmaceutical
11.2.1 Yichang Renfu Pharmaceutical Corporation Information
11.2.2 Yichang Renfu Pharmaceutical Overview
11.2.3 Yichang Renfu Pharmaceutical Remimazolam Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Yichang Renfu Pharmaceutical Remimazolam Product Description
11.2.5 Yichang Renfu Pharmaceutical Recent Developments
11.3 Jiangsu Hengrui Medicine
11.3.1 Jiangsu Hengrui Medicine Corporation Information
11.3.2 Jiangsu Hengrui Medicine Overview
11.3.3 Jiangsu Hengrui Medicine Remimazolam Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Jiangsu Hengrui Medicine Remimazolam Product Description
11.3.5 Jiangsu Hengrui Medicine Recent Developments
11.4 Cosmo Pharmaceuticals
11.4.1 Cosmo Pharmaceuticals Corporation Information
11.4.2 Cosmo Pharmaceuticals Overview
11.4.3 Cosmo Pharmaceuticals Remimazolam Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Cosmo Pharmaceuticals Remimazolam Product Description
11.4.5 Cosmo Pharmaceuticals Recent Developments
11.5 Mundipharma
11.5.1 Mundipharma Corporation Information
11.5.2 Mundipharma Overview
11.5.3 Mundipharma Remimazolam Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Mundipharma Remimazolam Product Description
11.5.5 Mundipharma Recent Developments
11.6 Pharmascience
11.6.1 Pharmascience Corporation Information
11.6.2 Pharmascience Overview
11.6.3 Pharmascience Remimazolam Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Pharmascience Remimazolam Product Description
11.6.5 Pharmascience Recent Developments
11.7 Hana Pharm
11.7.1 Hana Pharm Corporation Information
11.7.2 Hana Pharm Overview
11.7.3 Hana Pharm Remimazolam Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Hana Pharm Remimazolam Product Description
11.7.5 Hana Pharm Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Remimazolam Value Chain Analysis
12.2 Remimazolam Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Remimazolam Production Mode & Process
12.4 Remimazolam Sales and Marketing
12.4.1 Remimazolam Sales Channels
12.4.2 Remimazolam Distributors
12.5 Remimazolam Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Remimazolam Industry Trends
13.2 Remimazolam Market Drivers
13.3 Remimazolam Market Challenges
13.4 Remimazolam Market Restraints
14 Key Findings in The Global Remimazolam Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Remimazolam Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 2.5mg
Table 3. Major Manufacturers of 20mg
Table 4. Global Remimazolam Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Remimazolam Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Remimazolam Sales by Region (2016-2021) & (K Units)
Table 7. Global Remimazolam Sales Market Share by Region (2016-2021)
Table 8. Global Remimazolam Sales by Region (2022-2027) & (K Units)
Table 9. Global Remimazolam Sales Market Share by Region (2022-2027)
Table 10. Global Remimazolam Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Remimazolam Revenue Market Share by Region (2016-2021)
Table 12. Global Remimazolam Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Remimazolam Revenue Market Share by Region (2022-2027)
Table 14. Global Remimazolam Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Remimazolam Sales Share by Manufacturers (2016-2021)
Table 16. Global Remimazolam Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Remimazolam Revenue Share by Manufacturers (2016-2021)
Table 18. Remimazolam Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Remimazolam Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Remimazolam by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Remimazolam as of 2020)
Table 21. Remimazolam Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Remimazolam Product Offered
Table 23. Date of Manufacturers Enter into Remimazolam Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Remimazolam Sales by Type (2016-2021) & (K Units)
Table 26. Global Remimazolam Sales by Type (2022-2027) & (K Units)
Table 27. Global Remimazolam Sales Share by Type (2016-2021)
Table 28. Global Remimazolam Sales Share by Type (2022-2027)
Table 29. Global Remimazolam Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Remimazolam Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Remimazolam Revenue Share by Type (2016-2021)
Table 32. Global Remimazolam Revenue Share by Type (2022-2027)
Table 33. Remimazolam Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Remimazolam Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Remimazolam Sales by Application (2016-2021) & (K Units)
Table 36. Global Remimazolam Sales by Application (2022-2027) & (K Units)
Table 37. Global Remimazolam Sales Share by Application (2016-2021)
Table 38. Global Remimazolam Sales Share by Application (2022-2027)
Table 39. Global Remimazolam Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Remimazolam Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Remimazolam Revenue Share by Application (2016-2021)
Table 42. Global Remimazolam Revenue Share by Application (2022-2027)
Table 43. Remimazolam Price by Application (2016-2021) & (US$/Unit)
Table 44. Global Remimazolam Price Forecast by Application (2022-2027) & (US$/Unit)
Table 45. North America Remimazolam Sales by Type (2016-2021) & (K Units)
Table 46. North America Remimazolam Sales by Type (2022-2027) & (K Units)
Table 47. North America Remimazolam Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Remimazolam Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Remimazolam Sales by Application (2016-2021) & (K Units)
Table 50. North America Remimazolam Sales by Application (2022-2027) & (K Units)
Table 51. North America Remimazolam Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Remimazolam Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Remimazolam Sales by Country (2016-2021) & (K Units)
Table 54. North America Remimazolam Sales by Country (2022-2027) & (K Units)
Table 55. North America Remimazolam Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Remimazolam Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Remimazolam Sales by Type (2016-2021) & (K Units)
Table 58. Europe Remimazolam Sales by Type (2022-2027) & (K Units)
Table 59. Europe Remimazolam Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Remimazolam Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Remimazolam Sales by Application (2016-2021) & (K Units)
Table 62. Europe Remimazolam Sales by Application (2022-2027) & (K Units)
Table 63. Europe Remimazolam Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Remimazolam Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Remimazolam Sales by Country (2016-2021) & (K Units)
Table 66. Europe Remimazolam Sales by Country (2022-2027) & (K Units)
Table 67. Europe Remimazolam Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Remimazolam Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Remimazolam Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Remimazolam Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Remimazolam Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Remimazolam Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Remimazolam Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Remimazolam Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Remimazolam Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Remimazolam Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Remimazolam Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Remimazolam Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Remimazolam Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Remimazolam Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Remimazolam Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Remimazolam Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Remimazolam Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Remimazolam Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Remimazolam Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Remimazolam Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Remimazolam Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Remimazolam Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Remimazolam Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Remimazolam Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Remimazolam Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Remimazolam Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Remimazolam Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Remimazolam Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Remimazolam Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Remimazolam Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Remimazolam Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Remimazolam Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Remimazolam Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Remimazolam Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Remimazolam Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Remimazolam Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Remimazolam Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Remimazolam Revenue by Country (2022-2027) & (US$ Million)
Table 105. Paion Corporation Information
Table 106. Paion Description and Major Businesses
Table 107. Paion Remimazolam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. Paion Remimazolam Product
Table 109. Paion Recent Developments
Table 110. Yichang Renfu Pharmaceutical Corporation Information
Table 111. Yichang Renfu Pharmaceutical Description and Major Businesses
Table 112. Yichang Renfu Pharmaceutical Remimazolam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Yichang Renfu Pharmaceutical Remimazolam Product
Table 114. Yichang Renfu Pharmaceutical Recent Developments
Table 115. Jiangsu Hengrui Medicine Corporation Information
Table 116. Jiangsu Hengrui Medicine Description and Major Businesses
Table 117. Jiangsu Hengrui Medicine Remimazolam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Jiangsu Hengrui Medicine Remimazolam Product
Table 119. Jiangsu Hengrui Medicine Recent Developments
Table 120. Cosmo Pharmaceuticals Corporation Information
Table 121. Cosmo Pharmaceuticals Description and Major Businesses
Table 122. Cosmo Pharmaceuticals Remimazolam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Cosmo Pharmaceuticals Remimazolam Product
Table 124. Cosmo Pharmaceuticals Recent Developments
Table 125. Mundipharma Corporation Information
Table 126. Mundipharma Description and Major Businesses
Table 127. Mundipharma Remimazolam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Mundipharma Remimazolam Product
Table 129. Mundipharma Recent Developments
Table 130. Pharmascience Corporation Information
Table 131. Pharmascience Description and Major Businesses
Table 132. Pharmascience Remimazolam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Pharmascience Remimazolam Product
Table 134. Pharmascience Recent Developments
Table 135. Hana Pharm Corporation Information
Table 136. Hana Pharm Description and Major Businesses
Table 137. Hana Pharm Remimazolam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Hana Pharm Remimazolam Product
Table 139. Hana Pharm Recent Developments
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Remimazolam Distributors List
Table 143. Remimazolam Customers List
Table 144. Remimazolam Market Trends
Table 145. Remimazolam Market Drivers
Table 146. Remimazolam Market Challenges
Table 147. Remimazolam Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Remimazolam Product Picture
Figure 2. Global Remimazolam Market Share by Type in 2020 & 2027
Figure 3. 2.5mg Product Picture
Figure 4. 20mg Product Picture
Figure 5. Global Remimazolam Market Share by Application in 2020 & 2027
Figure 6. Surgical Anesthesia
Figure 7. ICU Sedation
Figure 8. Other
Figure 9. Remimazolam Report Years Considered
Figure 10. Global Remimazolam Sales 2016-2027 (K Units)
Figure 11. Global Remimazolam Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Remimazolam Revenue 2016-2027 (US$ Million)
Figure 13. Global Remimazolam Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Remimazolam Sales Market Share by Region (2016-2021)
Figure 15. Global Remimazolam Sales Market Share by Region (2022-2027)
Figure 16. North America Remimazolam Sales YoY (2016-2027) & (K Units)
Figure 17. North America Remimazolam Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Remimazolam Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Remimazolam Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Remimazolam Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Remimazolam Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Remimazolam Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Remimazolam Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Remimazolam Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Remimazolam Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Remimazolam Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Remimazolam Revenue in 2020
Figure 28. Remimazolam Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Remimazolam Sales Market Share by Type (2016-2027)
Figure 30. Global Remimazolam Revenue Market Share by Type (2016-2027)
Figure 31. Global Remimazolam Sales Market Share by Application (2016-2027)
Figure 32. Global Remimazolam Revenue Market Share by Application (2016-2027)
Figure 33. North America Remimazolam Sales Market Share by Type (2016-2027)
Figure 34. North America Remimazolam Revenue Market Share by Type (2016-2027)
Figure 35. North America Remimazolam Sales Market Share by Application (2016-2027)
Figure 36. North America Remimazolam Revenue Market Share by Application (2016-2027)
Figure 37. North America Remimazolam Sales Share by Country (2016-2027)
Figure 38. North America Remimazolam Revenue Share by Country (2016-2027)
Figure 39. United States Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Remimazolam Sales Market Share by Type (2016-2027)
Figure 42. Europe Remimazolam Revenue Market Share by Type (2016-2027)
Figure 43. Europe Remimazolam Sales Market Share by Application (2016-2027)
Figure 44. Europe Remimazolam Revenue Market Share by Application (2016-2027)
Figure 45. Europe Remimazolam Sales Share by Country (2016-2027)
Figure 46. Europe Remimazolam Revenue Share by Country (2016-2027)
Figure 47. Germany Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 48. France Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Remimazolam Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Remimazolam Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Remimazolam Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Remimazolam Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Remimazolam Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Remimazolam Revenue Share by Region (2016-2027)
Figure 58. China Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 61. India Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 63. Taiwan Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Remimazolam Sales Market Share by Type (2016-2027)
Figure 68. Latin America Remimazolam Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Remimazolam Sales Market Share by Application (2016-2027)
Figure 70. Latin America Remimazolam Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Remimazolam Sales Share by Country (2016-2027)
Figure 72. Latin America Remimazolam Revenue Share by Country (2016-2027)
Figure 73. Mexico Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 76. Colombia Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Remimazolam Sales Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Remimazolam Revenue Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Remimazolam Sales Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Remimazolam Revenue Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Remimazolam Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Remimazolam Revenue Share by Country (2016-2027)
Figure 83. Turkey Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 85. UAE Remimazolam Revenue (2016-2027) & (US$ Million)
Figure 86. Remimazolam Value Chain
Figure 87. Remimazolam Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
PVC麻酔マスクのグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global PVC Anesthesia Masks Market The global PVC Anesthesia Masks market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global PVC Anesthesia Masks Scope and Segment PVC Anes…- 眼手術台のグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Ophthalmic Surgical Table Market The global Ophthalmic Surgical Table market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027. Global Ophthalmic Surgical Table Scope and Segment O…
- 健康診断・手術用ゴム手袋のグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Medical Examination and Surgical Rubber Gloves Market The global Medical Examination and Surgical Rubber Gloves market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027. Global Med…
- 使い捨てLMA（ラリンジアルマスクエアウェイ）のグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Single-Use LMA (Laryngeal Mask Airway) Market The global Single-Use LMA (Laryngeal Mask Airway) market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Single-Use …
- リポフィリングガンのグローバル市場インサイト・予測（～2027年） An instrument for collecting and re injecting a patient's own adipocytes. Market Analysis and Insights: Global Lipofilling Gun Market The global Lipofilling Gun market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027…